BioDOptix® amniotic membrane
BioDOptix® amniotic extracellular matrix is a dehydrated membrane allograft derived from human amniotic tissue that is intended for use in ocular tissue repair. Human amniotic membrane has been used to treat a variety of wounds for over 100 years and the first reported use for ocular surface defects was reported in 1940
by De Roth. Research has shown that placental tissues can promote new tissue formation, reduce scar tissue formation, modulate inflammation and pain and may have antimicrobial effects.